Thursday , October 19 2017
Home / Letter From The Editor / July 16, 2016

July 16, 2016

daveWhen I was was doing a lot of diabetes management and pump starts, U-500 was always a fear causer for many medical professionals. Part of this came from problems with the conversion from a U-100 dose to an equivalent U-500 dose. Even though you simply divided the unit dose by 5 —  i.e. 100 units of U-100 became 20 units of U-500 — there was a fear of making a mistake. For years Lilly asked us to think of the syringe as “unit markings” rather than units, and that made it easier. But many health professionals still never took advantage of the higher strength insulin, and it was only in the last year that Lilly came out with a U-500 pen that takes the guesswork away. This would be perfect, except the vial is a cheaper option, and so many insurers will only cover the vial. This week B-D announced that they had come up with a syringe made for U-500 insulin. There were no pictures available with this announcement or at their website, so we will have to see what B-D has done to make this syringe “safe.”

Back in 2005 we ran an article on Type 3 diabetes, but not much more has been written about how it may be a precursor to Alzheimer’s. This week our LECOM Doctor of Pharmacy candidate, Priscilla Sakyi, has found some new information that links the use of anti-diabetic medications to the reduction in Alzheimer’s.

*****************************

We can make a difference!

*****************************

Dave Joffe, Editor-in-chief